World's Best Scientists 2026 revealed!
Michael Van Ameringen

Michael Van Ameringen

D-Index & Metrics

Psychology

D-Index
54
Citations
10585
World Ranking
4623
National Ranking
310

Overview

Michael Van Ameringen is affiliated with McMaster University in Canada and has contributed extensively to research in the fields of Psychology and Medicine. Their work primarily spans Clinical Psychology, Experimental and Cognitive Psychology, Psychiatry and Mental Health, Pharmacology, and Cognitive Neuroscience.

The scientist's research focuses on several key topics, including:

  • Obsessive-Compulsive Spectrum Disorders
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Child and Adolescent Psychosocial and Emotional Development
  • Attention Deficit Hyperactivity Disorder
  • Eating Disorders and Behaviors
  • Impact of Technology on Adolescents
  • Cannabis and Cannabinoid Research

Van Ameringen has published numerous papers in a variety of reputable journals. Some recent examples include:

  • "How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology" (2020, Comprehensive Psychiatry)
  • "Advances in problematic usage of the internet research - A narrative review by experts from the European network for problematic usage of the internet" (2022, Comprehensive Psychiatry)
  • "Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults" (2024, The Canadian Journal of Psychiatry)
  • "Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders" (2020, International Clinical Psychopharmacology)
  • "Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users" (2020, Comprehensive Psychiatry)

The frequent publication venues for Van Ameringen's work include:

  • Comprehensive Psychiatry
  • Journal of Psychiatric Research
  • The Canadian Journal of Psychiatry
  • Neuroscience Applied
  • International Clinical Psychopharmacology

Van Ameringen's collaborations reflect recurring partnerships with several researchers. Frequent co-authors include:

  • Beth Patterson
  • Naomi Fineberg
  • Dan J. Stein
  • Bernardo Dell'Osso
  • Eric Hollander

Best Publications

  • Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

    Martin A Katzman;Pierre Bleau;Pierre Blier;Pratap Chokka

  • World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

    Borwin Bandelow;Josef Zohar;Eric Hollander;Siegfried Kasper

  • The impact of anxiety disorders on educational achievement.

    Michael Van Ameringen;Michael Van Ameringen;Catherine Mancini;Catherine Mancini;Peter Farvolden

  • Post-traumatic stress disorder in Canada.

    Michael Van Ameringen;Michael Van Ameringen;Catherine Mancini;Catherine Mancini;Beth Patterson;Michael H. Boyle

  • Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study

    Michael A. Van Ameringen;Roger M. Lane;John R. Walker;Rudradeo C. Bowen

  • There is an app for that! The current state of mobile applications (apps) for DSM‐5 obsessive‐compulsive disorder, posttraumatic stress disorder, anxiety and mood disorders

    Michael Van Ameringen;Michael Van Ameringen;Jasmine Turna;Zahra Khalesi;Katrina Pullia

  • Quality of life and the anxiety disorders

    Lena C. Quilty;Michael Van Ameringen;Catherine Mancini;Jonathan Oakman

  • CHILDHOOD MALTREATMENT LINKED TO GREATER SYMPTOM SEVERITY AND POORER QUALITY OF LIFE AND FUNCTION IN SOCIAL ANXIETY DISORDER

    Naomi M. Simon;Nannette N. Herlands;Elizabeth H. Marks;Catherine Mancini

  • How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology.

    N. A. Fineberg;M. Van Ameringen;L. Drummond;E. Hollander

  • A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania

    Michael Van Ameringen;Catherine Mancini;Beth Patterson;Mark Bennett

  • Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

    Paul D Carey;Bavanisha Vythilingum;Soraya Seedat;Jacqueline E Muller

  • Early intervention for obsessive compulsive disorder: An expert consensus statement

    Naomi A. Fineberg;Naomi A. Fineberg;Bernardo Dell'Osso;Umberto Albert;Giuseppe Maina

  • Comorbidity in obsessive-compulsive disorder (OCD) : a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)

    Christine Lochner;Naomi A. Fineberg;Joseph Zohar;Michael Van Ameringen

  • DSM‐5 OBSESSIVE‐COMPULSIVE AND RELATED DISORDERS: CLINICAL IMPLICATIONS OF NEW CRITERIA

    Michael Van Ameringen;Beth Patterson;William Simpson;William Simpson

  • The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study

    Mark H. Pollack;Peter P. Roy-Byrne;Michael Van Ameringen;Heather Snyder

  • A High-Risk Pilot Study of the Children of Adults with Social Phobia

    Catherine Mancini;Michael Van Ameringen;Peter Szatmari;Christina Fugere

  • A confirmatory factor analysis of a self-report version of the Liebowitz Social Anxiety Scale.

    Jonathan Oakman;Michael Van Ameringen;Catherine Mancini;Peter Farvolden

  • World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders

    Unknown

  • Sertraline in social phobia

    Michael Van Ameringen;Catherine Mancini;David Streiner

  • Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders

    Naomi A. Fineberg;Naomi A. Fineberg;Naomi A. Fineberg;Eric Hollander;Stefano Pallanti;Stefano Pallanti;Susanne Walitza

  • Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series.

    Michael Van Ameringen;Catherine Mancini;Beth Patterson;Mark Bennett

  • Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia

    Michael Van Ameringen;Catherine Mancini;Carol Wilson

  • Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial

    Siegfried Kasper;Barry Herman;Giancarlo Nivoli;Michael Van Ameringen

Frequent Co-Authors

Catherine Mancini
Catherine Mancini McMaster University
Stefano Pallanti
Stefano Pallanti Albert Einstein College of Medicine
Naomi A. Fineberg
Naomi A. Fineberg University of Hertfordshire
Bernardo Dell'Osso
Bernardo Dell'Osso University of Milan
Joseph Zohar
Joseph Zohar Sheba Medical Center
Donatella Marazziti
Donatella Marazziti University of Pisa
Damiaan Denys
Damiaan Denys University of Amsterdam
Murray B. Stein
Murray B. Stein University of California, San Diego
Louis A. Schmidt
Louis A. Schmidt McMaster University
Naomi M. Simon
Naomi M. Simon New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring psychology in the USA opens doors to many rewarding career pathways. One popular field is school counseling, which requires specialized education and certification that can differ significantly by state. If you are considering a career as a school counselor, it’s important to understand the specific requirements where you plan to work.

In Minnesota, for example, Minnesota school counselor education requirements highlight the need for a master’s degree in school counseling and state-approved coursework. Meanwhile, becoming a school counselor in Mississippi involves completing an approved graduate program and passing the Praxis exam.

If you are interested in the Midwest, check out the Missouri school counselor education requirements, which stress the value of internship experience. For those targeting the Northwest, Montana school counselor education requirements include supervised counseling experience and state licensing.

Many universities now offer flexible online psychology and counseling degrees that can help you meet these educational criteria. Research your state’s guidelines carefully to choose the right academic path and ensure your credentials meet local licensing standards.

Best Scientists Citing Michael Van Ameringen

Trending Scientists

Recently Published Articles